Table of Contents

1 Market Overview

• 1.1 Objectives of Research
  • 1.1.1 Definition
  • 1.1.2 Specifications
• 1.2 Market Segment
  • 1.2.1 by Type
    • 1.2.1.1 PDE5
    • 1.2.1.2 PDE4
    • 1.2.1.3 Viagra
    • 1.2.1.4 Cialis
    • 1.2.1.5 Levitra
    • 1.2.1.6 Others
  • 1.2.2 by Application
    • 1.2.2.1 Genitourinary
    • 1.2.2.2 Cardiovascular Diseases
    • 1.2.2.3 Neurological Diseases
    • 1.2.2.4 Dermatological Disorders
    • 1.2.2.5 Respiratory Diseases
    • 1.2.2.6 Other Indications
  • 1.2.3 by Regions

2 Industry Chain

• 2.1 Industry Chain Structure
• 2.2 Upstream
• 2.3 Market
  • 2.3.1 SWOT
  • 2.3.2 Dynamics

3 Environmental Analysis

• 3.1 Policy
• 3.2 Economic
• 3.3 Technology
• 3.4 Market Entry

4 Market Segmentation by Type

• 4.1 Market Size
  • 4.1.1 PDE5 Market, 2013-2018
  • 4.1.2 PDE4 Market, 2013-2018
  • 4.1.3 Viagra Market, 2013-2018
  • 4.1.4 Cialis Market, 2013-2018
  • 4.1.5 Levitra Market, 2013-2018
  • 4.1.6 Others Market, 2013-2018
• 4.2 Market Forecast
  • 4.2.1 PDE5 Market Forecast, 2019-2024
  • 4.2.2 PDE4 Market Forecast, 2019-2024
  • 4.2.3 Viagra Market Forecast, 2019-2024
  • 4.2.4 Cialis Market Forecast, 2019-2024
  • 4.2.5 Levitra Market Forecast, 2019-2024
  • 4.2.6 Others Market Forecast, 2019-2024

5 Market Segmentation by Application

• 5.1 Market Size
  • 5.1.1 Genitourinary Market, 2013-2018
  • 5.1.2 Cardiovascular Diseases Market, 2013-2018
  • 5.1.3 Neurological Diseases Market, 2013-2018
  • 5.1.4 Dermatological Disorders Market, 2013-2018
  • 5.1.5 Respiratory Diseases Market, 2013-2018
  • 5.1.6 Other Indications Market, 2013-2018
• 5.2 Market Forecast
  • 5.2.1 Genitourinary Market Forecast, 2019-2024
  • 5.2.2 Cardiovascular Diseases Market Forecast, 2019-2024
  • 5.2.3 Neurological Diseases Market Forecast, 2019-2024
  • 5.2.4 Dermatological Disorders Market Forecast, 2019-2024
  • 5.2.5 Respiratory Diseases Market Forecast, 2019-2024
  • 5.2.6 Other Indications Market Forecast, 2019-2024

6 Market Segmentation by Region

• 6.1 Market Size
  • 6.1.1 Asia-Pacific
    • 6.1.1.1 Asia-Pacific Market, 2012-2018
    • 6.1.1.2 Asia-Pacific Market by Type
    • 6.1.1.3 Asia-Pacific Market by Application
  • 6.1.2 North America
    • 6.1.2.1 North America Market, 2012-2018
    • 6.1.2.2 North America Market by Type
    • 6.1.2.3 North America Market by Application
  • 6.1.3 Europe
    • 6.1.3.1 Europe Market, 2012-2018
    • 6.1.3.2 Europe Market by Type
    • 6.1.3.3 Europe Market by Application
  • 6.1.4 South America
    • 6.1.4.1 South America Market, 2012-2018
    • 6.1.4.2 South America Market by Type
    • 6.1.4.3 South America Market by Application
  • 6.1.5 Middle East & Africa
    • 6.1.5.1 Middle East & Africa Market, 2012-2018
    • 6.1.5.2 Middle East & Africa Market by Type
    • 6.1.5.3 Middle East & Africa Market by Application
• 6.2 Market Forecast
  • 6.2.1 Asia-Pacific Market Forecast, 2019-2024
  • 6.2.2 North America Market Forecast, 2019-2024
  • 6.2.3 Europe Market Forecast, 2019-2024
  • 6.2.4 South America Market Forecast, 2019-2024
  • 6.2.5 Middle East & Africa Market Forecast, 2019-2024

7 Market Competitive

• 7.1 Global Market by Vendors
• 7.2 Market Concentration
• 7.3 Price & Factors
• 7.4 Marketing Channel

8 Major Vendors

• 8.1 Hanmi Science Holding
• 8.2 Boehringer Ingelheim
• 8.3 Takeda Pharmaceuticals
• 8.4 Pfizer
• 8.5 Omeros
• 8.6 Anacor Pharmaceuticals
• 8.7 Otsuka
• 8.8 Chiesi Farmaceutici
• 8.9 Verona Pharma
• 8.10 NuSirt Biopharma

9 Conclusion

Summary
The global PDE Inhibitors market will reach xxx Million USD in 2019 with CAGR xx% 2019-2024. The objective of report is to define, segment, and project the market on the basis of product type, application, and region, and to describe the content about the factors influencing market dynamics, policy, economic, technology and market entry etc.
Based on products type, the report describes major products type share of regional market. Products mentioned as follows:
PDE5
PDE4
Viagra
Cialis
Levitra
Others
Leading vendors in the market are included based on profile, business performance etc. Vendors mentioned as follows:
Hanmi Science Holding
Boehringer Ingelheim
Takeda Pharmaceuticals
Pfizer
Omeros
Anacor Pharmaceuticals
Otsuka
Chiesi Farmaceutici
Verona Pharma
NuSirt Biopharma
Based on Application, the report describes major application share of regional market. Application mentioned as follows:
Genitourinary
Cardiovascular Diseases
Neurological Diseases
Dermatological Disorders
Respiratory Diseases
Other Indications
Based on region, the report describes major regions market by products and application. Regions mentioned as follows:
Asia-Pacific
North America
Europe
South America
Middle East & Africa